SCHEMBL5585973

SCHEMBL5585973

CCCc1ccc(-c2cnc(CBr)o2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.43
RXRA P19793 2/20 0.43
RXRB P28702 2/20 0.43
RXRG P48443 2/20 0.43
FFAR1 O14842 1/20 0.40
HDAC1 Q13547 4/20 0.39
HDAC2 Q92769 4/20 0.39
HDAC3 O15379 3/20 0.39
HDAC4 P56524 3/20 0.39
HDAC7 Q8WUI4 3/20 0.39
HDAC10 Q969S8 3/20 0.39
HDAC11 Q96DB2 3/20 0.39
HDAC8 Q9BY41 3/20 0.39
HDAC6 Q9UBN7 3/20 0.39
HDAC9 Q9UKV0 3/20 0.39
HDAC5 Q9UQL6 3/20 0.39
NISCH Q9Y2I1 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8555120 0.76 NOTUM (0.68) NOTUMRXRARXRBRXRGFFAR1
SCHEMBL15427231 0.73 NOTUM (0.64) NOTUMRXRARXRBRXRGFFAR1
SCHEMBL13744529 0.72 KDM4E (0.49) NOTUMRXRARXRBRXRGHDAC1
SCHEMBL22556732 0.71 NOTUM (0.49) NOTUMRXRARXRBRXRGFFAR1
SCHEMBL6629375 0.71 NOTUM (0.45) NOTUMRXRARXRBRXRGFFAR1
SCHEMBL5585932 0.71 MAPT (0.37) NISCHNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL2219797 0.69 HRH3 (0.45) NISCHNPC1RAB9AMAPTGFER
SCHEMBL14403485 0.69 NPC1 (0.58) RXRARXRBRXRGNPC1RAB9A
SCHEMBL15621589 0.68 NOTUM (0.60) NOTUMRXRARXRBRXRGFFAR1
SCHEMBL11621352 0.68 HDAC1 (0.49) NOTUMRXRARXRBRXRGHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070244130-A1 Compounds and Compositions as Ppar Modulators IRM LLC (BM) 2007-10-18 US disclosed
US-20070244130-A1 Compounds and Compositions as Ppar Modulators IRM LLC (BM) 2007-10-18 US disclosed
US-20070244130-A1 Compounds and Compositions as Ppar Modulators IRM LLC (BM) 2007-10-18 US disclosed
EP-1749003-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2007-02-07 EP disclosed
WO-2005116016-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2005-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244130-A1 Compounds and Compositions as Ppar Modulators PPARG, PPARA, PPARD NOTUM 1445/4885RXRA 9/4885RXRB 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.